Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Feasibility Study of Fecal Microbiota Transplantation (FMT) in Patients With Malignancies Not Responding to Cancer Immunotherapy (CI)

NCT05273255 is registered in ClinicalTrials.gov with Michael Scharl as lead sponsor.

NCT NCT05273255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05273255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Feasibility Study of Fecal Microbiota Transplantation (FMT) in Patients With Malignancies Not Responding to Cancer Immunotherapy (CI)
Lead sponsor
Michael Scharl
Phase
Not applicable
Overall status
Completed
Start date
March 14, 2022
Completion date
October 24, 2024
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, fecal microbiota transplantation, immune checkpoint inhibitors, immunotherapy